相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial
Geltrude Mingrone et al.
LANCET (2021)
Best Practices in the Management of Overweight and Obesity
Beverly G. Tchang et al.
MEDICAL CLINICS OF NORTH AMERICA (2021)
Metformin-induced weight loss in patients with or without type 2 diabetes/prediabetes: A retrospective cohort study
Tariq Chukir et al.
OBESITY RESEARCH & CLINICAL PRACTICE (2021)
Changes in Utilization of Bariatric Surgery in the United States From 1993 to 2016
Guilherme M. Campos et al.
ANNALS OF SURGERY (2020)
Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures-2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists
Jeffrey I. Mechanick et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2020)
Bariatric Surgery vs Lifestyle Intervention for Diabetes Treatment: 5-Year Outcomes From a Randomized Trial
Anita P. Courcoulas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
GDF15 mediates the effects of metformin on body weight and energy balance
Anthony P. Coll et al.
NATURE (2020)
Long-acting GLP-1RAs An overview of efficacy, safety, and their role in type 2 diabetes management
Ji Hyun Chun et al.
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS (2020)
Life Expectancy after Bariatric Surgery in the Swedish Obese Subjects Study
Lena M. S. Carlsson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Alison B. Evert et al.
DIABETES CARE (2019)
Review of cardiovascular outcomes trials of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists
Emily J. North et al.
CURRENT OPINION IN CARDIOLOGY (2019)
Projected US State-Level Prevalence of Adult Obesity and Severe Obesity
Zachary J. Ward et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Economic Costs of Diabetes in the US in 2017
Wenya Yang et al.
DIABETES CARE (2018)
Diabetes management before, during, and after bariatric and metabolic surgery
Karim G. Kheniser et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2018)
The Carbohydrate-Insulin Model of Obesity Beyond Calories In, Calories Out
David S. Ludwig et al.
JAMA INTERNAL MEDICINE (2018)
Physical Activity Guidelines for Americans From the US Department of Health and Human Services Cardiovascular Benefits and Recommendations
Katrina L. Piercy et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2018)
Sustained influence of metformin therapy on circulating glucagon-like peptide-1 levels in individuals with and without type 2 diabetes
David Preiss et al.
DIABETES OBESITY & METABOLISM (2017)
Bariatric Surgery versus Intensive Medical Therapy for Diabetes-5-Year Outcomes
Philip R. Schauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes
Fernando Gomez-Peralta et al.
DIABETES THERAPY (2017)
Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes
Fernando Gomez-Peralta et al.
DIABETES THERAPY (2017)
Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity
Faidon Magkos et al.
CELL METABOLISM (2016)
Physical Activity/Exercise and Diabetes: A Position Statement of the American Diabetes Association
Sheri R. Colberg et al.
DIABETES CARE (2016)
Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study
Vanita R. Aroda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Weight Management in Type 2 Diabetes: Current and Emerging Approaches to Treatment
Luc Van Gaal et al.
DIABETES CARE (2015)
Insulin dose adjustments with add-on glucagon-like peptide-1 receptor (GLP-1R) agonists in clinical practice
Carla Frances Artigas et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Intensive versus conventional glucose control in critically ill patients with traumatic brain injury: long-term follow-up of a subgroup of patients from the NICE-SUGAR study
Simon Finfer
INTENSIVE CARE MEDICINE (2015)
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes The SCALE Diabetes Randomized Clinical Trial
Melanie J. Davies et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
Caroline M Apovian et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial
Geltrude Mingrone et al.
LANCET (2015)
Weight-Loss Therapy in Type 2 Diabetes: Effects of Phentermine and Topiramate Extended Release
W. Timothy Garvey et al.
DIABETES CARE (2014)
Quantitative relationship between body weight gain in adulthood and incident type 2 diabetes: a meta-analysis
S. Kodama et al.
OBESITY REVIEWS (2014)
Place of sodium-glucose co-transporter type 2 inhibitors for treatment of type 2 diabetes
Nasser Mikhail
WORLD JOURNAL OF DIABETES (2014)
Do GLP-1-Based Therapies Increase Cancer Risk?
Michael A. Nauck et al.
DIABETES CARE (2013)
Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes
Priscilla Hollander et al.
DIABETES CARE (2013)
Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
Rena Wing et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The effect of metformin on food intake and its potential role in hypothalamic regulation in obese diabetic rats
Wen-shan Lv et al.
BRAIN RESEARCH (2012)
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
Kishore M. Gadde et al.
LANCET (2011)
The magnitude of association between overweight and obesity and the risk of diabetes: A meta-analysis of prospective cohort studies
Asnawi Abdullah et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study
G. A. Bray et al.
LANCET (2009)
Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic
Youfa Wang et al.
OBESITY (2008)
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Steven E. Kahn et al.
NATURE (2006)
Effects of different modes of exercise training on glucose control and risk factors for complications in type 2 diabetic patients - A meta-analysis
Neil J. Snowling et al.
DIABETES CARE (2006)
Association of healthcare costs with per unit body mass index increase
Feifei Wang et al.
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2006)
A randomized study of orlistat in combination with a weight management programme in obese patients with Type 2 diabetes treated with metformin
C Berne
DIABETIC MEDICINE (2005)
Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies
C Barba et al.
LANCET (2004)
The effects of orlistat on body weight and glycaemic control in overweight patients with type 2 diabetes: a randomized, placebo-controlled trial
M Hanefeld et al.
DIABETES OBESITY & METABOLISM (2002)
Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin
JM Miles et al.
DIABETES CARE (2002)
Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes - A 1-year randomized controlled trial
DE Kelley et al.
DIABETES CARE (2002)
分享论文
